AbsEn.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « reports »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
reporting < reports < reposition  Facettes :

List of bibliographic references indexed by reports

Number of relevant bibliographic references: 93.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000023 (2021) Consuelo Luna-Mu Oz [Pérou] ; Giuliana Reyes-Florian [Pérou] ; Martin Seminario-Aliaga [Pérou] ; Angie Stapleton-Herbozo [Pérou] ; Lucy E. Correa-L Pez [Pérou] ; Dante M. Qui Ones-Laveriano [Pérou][Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital].
000035 (2021) L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A MarcialisWhat if COVID-19 affects the child: which weapons and how to use them.
000061 (2021) Neils Ben Quashie [Ghana] ; Nancy Odurowah Duah-Quashie [Ghana]Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries.
000077 (2021) Muhammad Sani Ismaila [Trinité-et-Tobago] ; Faruku Bande [Nigeria] ; Aminu Ishaka [Nigeria] ; Aminatu Abubakar Sani [Nigeria] ; Karla Georges [Trinité-et-Tobago]Therapeutic options for COVID-19: a quick review.
000094 (2021) Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde]The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
000097 (2021) Jack Cook [États-Unis] ; Milton L. Pressler [États-Unis] ; Bharat Damle [États-Unis] ; Demissie Alemayehu [États-Unis] ; Charles A. Knirsch [États-Unis]The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin.
000181 (2021) Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde]Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
000227 (2021) Iwein Gyselinck [Belgique] ; Wim Janssens [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique]Rationale for azithromycin in COVID-19: an overview of existing evidence.
000249 (2021) Bianza Moise Bakadia ; Feng He [République populaire de Chine] ; Tiatou Souho [Togo] ; Lallepak Lamboni [Togo] ; Muhammad Wajid Ullah [République populaire de Chine] ; Biaou Ode Boni [République populaire de Chine] ; Abeer Ahmed Qaed Ahmed [République populaire de Chine] ; Biampata Mutu Mukole ; Guang Yang [République populaire de Chine]Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine.
000367 (2021) Hernando Trujillo [Espagne] ; Mario Fernández-Ruiz [Espagne] ; Eduardo Gutiérrez [Espagne] ; Ángel Sevillano [Espagne] ; Fernando Caravaca-Fontán [Espagne] ; Enrique Morales [Espagne] ; Francisco L Pez-Medrano [Espagne] ; José María Aguado [Espagne] ; Manuel Praga [Espagne] ; Amado Andrés [Espagne]Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
000373 (2021) Irina Panovska-Stavridis ; Nevenka Ridova ; Tatjana Stojanoska ; Ilir Demiri ; Milena Stevanovic ; Simona Stojanovska ; Tara Ristevska ; Aleksandar Dimkovski ; Venko Filipce ; Aleksandar Dimovski ; Aleksandra GrozdanovaInsight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
000494 (2021) Wang-Da Liu [Taïwan] ; Sui-Yuan Chang [Taïwan] ; Ting-Yuan Lan [Taïwan] ; Yen-Chun Lin [Taïwan] ; Jui-Hung Kao [Taïwan] ; Chun-Hua Liao [Taïwan] ; Ming-Jui Tsai [Taïwan] ; Po-Hsien Kuo [Taïwan] ; Yu-Shan Huang [Taïwan] ; Jann-Tay Wang [Taïwan] ; Wang-Huei Sheng [Taïwan] ; Song-Chou Hsieh [Taïwan] ; Bor-Luen Chiang [Taïwan] ; Yee-Chun Chen [Taïwan] ; Shan-Chwen Chang [Taïwan]Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics.
000653 (2021) Adam Goldman [Israël] ; David Bomze [Israël, Suisse] ; Rachel Dankner [Israël] ; Hanoch Hod [Israël] ; Tomer Meirson [Israël] ; Ben Boursi [Israël, États-Unis] ; Elad Maor [Israël]Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
000663 (2021) Miroslaw Kiedrowski [Pologne] ; Przemyslaw Kapala [Pologne] ; Marlena Kiedrowska [Pologne] ; Anna Skoczynska [Pologne] ; Aleksandra Czerw [Pologne] ; Andrzej Deptała [Pologne]Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19.
000674 (2021) Hussain Ahmed Raza [Pakistan] ; Javeria Tariq [Pakistan] ; Vikas Agarwal [Inde] ; Latika Gupta [Inde]COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
000686 (2021) Carmen Guadalupe Rodriguez-Gonzalez [Espagne] ; Esther Chamorro-De-Vega [Espagne] ; Maricela Valerio [Espagne] ; Miguel Angel Amor-Garcia [Espagne] ; Francisco Tejerina [Espagne] ; Milagros Sancho-Gonzalez [Espagne] ; Alvaro Narrillos-Moraza [Espagne] ; Alvaro Gimenez-Manzorro [Espagne] ; Silvia Manrique-Rodriguez [Espagne] ; Marina Machado [Espagne] ; Maria Olmedo [Espagne] ; Vicente Escudero-Vilaplana [Espagne] ; Cristina Villanueva-Bueno [Espagne] ; Beatriz Torroba-Sanz [Espagne] ; Alejandra Melgarejo-Ortu O [Espagne] ; Juan Vicente-Valor [Espagne] ; Ana Herranz [Espagne] ; Emilio Bouza [Espagne] ; Patricia Mu Oz [Espagne] ; Maria Sanjurjo [Espagne]COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
000746 (2021) Andy On-Tik Wong [États-Unis] ; Bimal Gurung [Hong Kong] ; Wing Sum Wong [États-Unis] ; Suet Yee Mak [États-Unis] ; Wan Wai Tse [États-Unis] ; Chloe M. Li [Hong Kong] ; Deborah K. Lieu [États-Unis] ; Kevin D. Costa [États-Unis] ; Ronald A. Li [États-Unis] ; Roger J. Hajjar [États-Unis]Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues.
000759 (2021) Niloufar Najar Nobari [Iran] ; Farnoosh Seirafianpour [Iran] ; Farzaneh Mashayekhi [Iran] ; Azadeh Goodarzi [Iran]A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
000805 (2020) Naeem A. Alshoaibi [Arabie saoudite] ; Khadijah Maghrabi [Arabie saoudite] ; Haitham Alanazi [Arabie saoudite] ; Mousa Al Harbi [Arabie saoudite] ; Saleh Alghamdi [Arabie saoudite]Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.
000895 (2020) B K Anupama [États-Unis] ; Soumya Adhikari [États-Unis] ; Debanik Chaudhuri [États-Unis]Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin.
000906 (2020) Dinesh Kumar Badyal [Inde] ; Rajiv Mahajan [Inde]Chloroquine: Can it be a Novel Drug for COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "reports" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "reports" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    reports
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021